Related Experiment Video
Updated: May 15, 2026
10:38
DIPLOMA Approach for Standardized Pathology Assessment of Distal Pancreatectomy Specimens
Published on: February 1, 2020
Is there a 'margin' for error in pancreatic cancer surgery?
Adam E Frampton1, Tamara M H Gall, Jonathan Krell
1HPB Surgical Unit, Department of Surgery & Cancer, Imperial College, Hammersmith Hospital campus, Du Cane Road, London, W12 0HS, UK.
Future Oncology (London, England)
|December 21, 2012
Summary
Microscopic positive resection margins (R1) in pancreatic ductal adenocarcinoma (PDAC) surgery correlate with higher local recurrence and worse survival. Posterior R1 margins, especially with lymph node involvement, significantly increase recurrence risk.
Area of Science:
- Oncology
- Surgical Pathology
- Gastroenterology
Background:
- Pancreatic ductal adenocarcinoma (PDAC) has a poor prognosis despite surgical resection.
- Identifying factors influencing outcomes after surgery is crucial for improving patient survival.
Discussion:
- This study retrospectively analyzed patients undergoing surgical resection for PDAC.
- Outcomes were compared between negative (R0) and positive (R1) resection margins.
- Specific focus was placed on posterior margins and lymph node involvement.
Key Insights:
- Positive posterior resection margins (R1) are associated with increased local recurrence (LR) and reduced LR-free survival in PDAC.
- Lymph node involvement exacerbates the negative impact of R1 posterior margins on recurrence.
- Standardized pathological reporting is essential for further research into R1 patient management.
Outlook:
- Further investigation into optimizing surgical techniques and adjuvant therapies for R1 patients is warranted.
- Enhanced pathological reporting can facilitate a deeper understanding of factors influencing R1 outcomes.
- Improved management strategies for R1 pancreatic cancer may lead to better patient survival rates.
